Skip to main content

RETRACTION article

Front. Cardiovasc. Med., 15 October 2024
Sec. General Cardiovascular Medicine
Volume 11 - 2024 | https://doi.org/10.3389/fcvm.2024.1504298
This article is part of the Research Topic Case Reports in General Cardiovascular Medicine: 2022 View all 35 articles

Retraction: Case Report: Coronavirus disease 2019 (COVID-19) modified RNA vaccination-induced adult-onset still's disease with fulminant myocarditis as initial presentation

This article is a retraction of:

  1. RETRACTED: Case report: Coronavirus Disease 2019 (COVID-19) modified RNA vaccination-induced Adult-Onset Still's Disease with fulminant myocarditis as initial presentation

    1. Read original article
\r\nFrontiers Editorial Office\r\nFrontiers Editorial Office

A Retraction of the Case Report article

Coronavirus disease 2019 (COVID-19) modified RNA vaccination-induced adult-onset still’s disease with fulminant myocarditis as initial presentation

By Zhou M, Wong CK, Yeung WYW, Siu CW and Yin L (2023). Front. Cardiovasc. Med. 10:1066699. doi: 10.3389/fcvm.2023.1066699

Following publication, concerns were raised regarding the duplication of patient data in the article cited above in Frontiers in Cardiovascular Medicine and Hong Kong Medical Journal Kan A, Yeung W, Lau CS, Li P (2023) Adult-onset Still's disease after mRNA COVID-19 vaccination presenting with severe myocarditis with acute heart failure and cardiogenic shock: a case report Hong Kong Med J. 2023 Apr;29(2):162–4 | Epub 20 Mar 2023 https://doi.org/10.12809/hkmj2210110.

An investigation was conducted in accordance with Frontiers' policies, whereby it was confirmed that duplicate publication had occurred and the article has been retracted.

This retraction was approved by the Specialty Chief Editor of Cardiovascular Medicine. The author(s) agree to this Retraction.

Citation: Frontiers Editorial Office (2024) Retraction: Case Report: Coronavirus disease 2019 (COVID-19) modified RNA vaccination-induced adult-onset still's disease with fulminant myocarditis as initial presentation. Front. Cardiovasc. Med. 11:1504298. doi: 10.3389/fcvm.2024.1504298

Received: 30 September 2024; Accepted: 30 September 2024;
Published: 15 October 2024.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright: © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.